Follow-The-Filings

Security · featured owners

ZBIO Zenas Biopharma Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management exited 2026 Q2 last 2026 Q1 0.19% Exit −0.19 pp 42,500 $831K history

SEC filings

Recent issuer filings from EDGAR · 19 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,5.02,9.01
10-Q
8-K 2.02,5.02,5.07,9.01
10-Q
8-K 1.01,2.03,8.01,9.01
424B5
424B5
424B5
424B5
8-K 2.02,9.01
10-K
DEFA14A
8-K 5.02,9.01
424B7
8-K 2.02,7.01,8.01,9.01
8-K 5.02,9.01
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Jun 15, 2026 · 10 forms
4 Period May 18, 2026
4 Period Apr 28, 2026
4 Period Mar 31, 2026
4 Period Mar 31, 2026
4 Period Mar 31, 2026
4 Period Mar 30, 2026
4 Period Feb 12, 2026
4 Period Feb 11, 2026
4 Period Feb 2, 2026
4 Period Jan 7, 2026
4 Period Oct 9, 2025

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $5M $10M
Net income -$156.99M -$377.74M
Net margin * -3139.8% -3777.4%

Balance sheet

Metric FY2024 FY2025
Total current assets $355.92M $351.17M
Total non-current assets * $14.04M $32.47M
Total assets $369.97M $383.64M
Total current liabilities $57.29M $62.65M
Total non-current liabilities * $0.218M $78.85M
Total equity $312.46M $242.14M

Cash flow

Metric FY2024 FY2025
Cash from operations -$119.67M -$172.33M
Cash from investing -$30.55M -$251.89M
Cash from financing $412.96M $215.28M
Net change in cash $262.89M -$209.19M

ownership over time

filing count by report period · click a bar for that quarter’s holders